Where I see patients (4)
Selected research
-
Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
Clinical nuclear medicine
-
Choice is good at times: the emergence of [64Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [68Ga]Ga-DOTATATE.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Clinical trials
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology as compared to sestamibi imaging. Location of parathyroid adenoma at imaging as read by three blinded readers, will be ...
Recruiting
Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors
Radiologists will classify lesions based on imaging as either having recurrent disease or not having recurrent disease. True Positives (TP) are defined as an FET PET read positive for tumor and pathology/follow-up demonstrates tum...
Recruiting